Tensegrity Pharma is a Tokyo-based biotech startup with a mission to eliminate global bottlenecks in the discovery of new drugs. The company re-evaluates and revitalizes therapeutic projects that were strategically discontinued, aiming to conduct exploratory clinical development trials on a global scale to obtain clinical POC and maximize their value through out-licensing and M&A opportunities with biopharmaceutical companies. With a team comprised of members with experience at both major pharmaceutical firms and startups, Tensegrity Pharma leverages promising candidate compounds for clinical development, uncovering and delivering highly innovative drug seeds that address unmet medical and societal needs and contribute to further activating the drug discovery ecosystem in Japan. The company is also dedicated to nurturing globally-minded drug discovery talent originating from Japan.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1-9-10 Nihonbashi Horidomecho, Nihonbashi Life Science Build. 7,6f,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- IT Consulting.
- HQ
- Chuo-ku, Tokyo
Tensegrity Pharma, Inc. Questions
Tensegrity Pharma, Inc.'s website is https://tensegritypharma.com/contact.html
Tensegrity Pharma, Inc.'s LinkedIn profile is https://jp.linkedin.com/company/tensegrity-pharma
Tensegrity Pharma, Inc. has
4 employees.
View email and phone details for 4
employees at Tensegrity Pharma, Inc..
Tensegrity Pharma, Inc.'s industry is
Biotechnology Research
Tensegrity Pharma, Inc.'s top competitors are
Ml Bio Solutions,
Regcell,
Igs Works,
Cytea Bio,
Reborna Biosciences, Inc.,
Alivexis, Inc,
N-Of-One, Inc.,
Dual Move Co., Ltd.,
Mayumana Healthcare,
Datagateway Pte. Ltd..
Tensegrity Pharma, Inc.'s categories are Biotechnology Research
Tensegrity Pharma, Inc.'s founding year is 2023
